Cui L, Zhao S, Teng H, Yang B, Liu Q, Qin A
NPJ Precis Oncol. 2025; 9(1):19.
PMID: 39825088
PMC: 11742673.
DOI: 10.1038/s41698-024-00794-5.
Kim S, Park I, Kim J, Ka N, Lim G, Park M
Breast Cancer Res. 2025; 27(1):4.
PMID: 39789641
PMC: 11715970.
DOI: 10.1186/s13058-024-01958-8.
Liu W, Kovacs A, Hou J
Cells. 2024; 13(23).
PMID: 39682769
PMC: 11640528.
DOI: 10.3390/cells13232022.
Zhu Z, Liu H, Fu H, Luo Y, Chen B, Wu X
Sci Rep. 2024; 14(1):29659.
PMID: 39609464
PMC: 11604762.
DOI: 10.1038/s41598-024-75538-3.
Zhang Y, Hou H, Zhang X, Lan H, Huo X, Duan X
Dig Dis Sci. 2024; 70(1):262-284.
PMID: 39604668
DOI: 10.1007/s10620-024-08715-z.
Subverting to Prevent : Alteration of Effector Immune Cell Migration and Adhesion as a Key Mechanism of Tumor Immune Evasion.
Mastrogiovanni M, Donnadieu E, Pathak R, Di Bartolo V
Biology (Basel). 2024; 13(11).
PMID: 39596815
PMC: 11591779.
DOI: 10.3390/biology13110860.
The Link Between the Gut Microbiome and Bone Metastasis.
Sevcikova A, Martiniakova M, Omelka R, Stevurkova V, Ciernikova S
Int J Mol Sci. 2024; 25(22).
PMID: 39596154
PMC: 11593804.
DOI: 10.3390/ijms252212086.
Cell-cell interactions mediating primary and metastatic breast cancer dormancy.
Lenart N, Rao S
Cancer Metastasis Rev. 2024; 44(1):6.
PMID: 39585533
DOI: 10.1007/s10555-024-10223-5.
Differential bone morphology and hypoxia activity in skeletal metastases of ER and ER breast cancer.
Das A, Barry M, Ernst C, Dahiya R, Kim M, Rosario S
Commun Biol. 2024; 7(1):1545.
PMID: 39572705
PMC: 11582807.
DOI: 10.1038/s42003-024-07247-6.
Deciphering normal and cancer stem cell niches by spatial transcriptomics: opportunities and challenges.
Sarkar H, Lee E, Lopez-Darwin S, Kang Y
Genes Dev. 2024; 39(1-2):64-85.
PMID: 39496456
PMC: 11789490.
DOI: 10.1101/gad.351956.124.
Integrin β1 in breast cancer: mechanisms of progression and therapy.
Huang Q, Wang J, Ning H, Liu W, Han X
Breast Cancer. 2024; 32(1):43-59.
PMID: 39343856
DOI: 10.1007/s12282-024-01635-w.
The dual roles of lymphotoxin-β in promoting breast cancer bone metastasis.
Nat Cell Biol. 2024; 26(9):1384-1385.
PMID: 39198696
DOI: 10.1038/s41556-024-01479-8.
The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence.
Liu Y, Chen H, Chen T, Qiu G, Han Y
Front Oncol. 2024; 14:1445025.
PMID: 39148909
PMC: 11324560.
DOI: 10.3389/fonc.2024.1445025.
Lymphotoxin-β promotes breast cancer bone metastasis colonization and osteolytic outgrowth.
Wang X, Zhang T, Zheng B, Lu Y, Liang Y, Xu G
Nat Cell Biol. 2024; 26(9):1597-1612.
PMID: 39147874
DOI: 10.1038/s41556-024-01478-9.
An update to experimental and clinical aspects of tumor-associated macrophages in cancer development: hopes and pitfalls.
Salmaninejad A, Layeghi S, Falakian Z, Golestani S, Kobravi S, Talebi S
Clin Exp Med. 2024; 24(1):156.
PMID: 39003350
PMC: 11246281.
DOI: 10.1007/s10238-024-01417-w.
Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis.
Arakil N, Akhund S, Elaasser B, Mohammad K
Biomedicines. 2024; 12(5).
PMID: 38791037
PMC: 11117796.
DOI: 10.3390/biomedicines12051075.
Immune Cell Migration to Cancer.
Ryan A, Kim M, Lim K
Cells. 2024; 13(10.
PMID: 38786066
PMC: 11120175.
DOI: 10.3390/cells13100844.
Targeting initial tumour-osteoclast spatiotemporal interaction to prevent bone metastasis.
Gu C, Chen P, Tian H, Yang Y, Huang Z, Yan H
Nat Nanotechnol. 2024; 19(7):1044-1054.
PMID: 38499860
DOI: 10.1038/s41565-024-01613-5.
A Bioinspired Immunostimulatory System for Inducing Powerful Antitumor Immune Function by Directly Causing Plasma Membrane Rupture.
Hu X, Yin H, Xie D, Chen T, Li Y, Zeng H
Adv Sci (Weinh). 2024; 11(20):e2305934.
PMID: 38484186
PMC: 11132027.
DOI: 10.1002/advs.202305934.
Bridging the Gap in Understanding Bone Metastasis: A Multifaceted Perspective.
Elaasser B, Arakil N, Mohammad K
Int J Mol Sci. 2024; 25(5).
PMID: 38474093
PMC: 10932255.
DOI: 10.3390/ijms25052846.